EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C50H75N15O12 |
| Net Charge | +2 |
| Average Mass | 1078.243 |
| Monoisotopic Mass | 1077.57087 |
| SMILES | NC(=[NH2+])NCCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]([NH3+])CCCNC(N)=[NH2+])C(=O)[O-] |
| InChI | InChI=1S/C50H73N15O12/c51-32(15-7-19-56-49(52)53)45(73)64-22-10-18-38(64)47(75)65-27-31(67)25-39(65)43(71)58-26-40(68)59-34(23-29-11-3-1-4-12-29)41(69)62-36(28-66)46(74)63-21-9-17-37(63)44(72)61-35(24-30-13-5-2-6-14-30)42(70)60-33(48(76)77)16-8-20-57-50(54)55/h1-6,11-14,31-39,66-67H,7-10,15-28,51H2,(H,58,71)(H,59,68)(H,60,70)(H,61,72)(H,62,69)(H,76,77)(H4,52,53,56)(H4,54,55,57)/p+2/t31-,32+,33+,34+,35+,36+,37+,38+,39+/m1/s1 |
| InChIKey | JXRLHZCEMXTCBN-DIBGMJQNSA-P |
| Roles Classification |
|---|
| Biological Roles: | bradykinin receptor agonist An agonist that binds to and activates bradykinin receptors human urinary metabolite Any metabolite (endogenous or exogenous) found in human urine samples. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| [Hyp3]-bradykinin(2+) (CHEBI:133054) has role bradykinin receptor agonist (CHEBI:77495) |
| [Hyp3]-bradykinin(2+) (CHEBI:133054) has role human urinary metabolite (CHEBI:84087) |
| [Hyp3]-bradykinin(2+) (CHEBI:133054) is a peptide cation (CHEBI:60194) |
| [Hyp3]-bradykinin(2+) (CHEBI:133054) is conjugate acid of [Hyp3]-bradykinin (CHEBI:133051) |
| Incoming Relation(s) |
| [Hyp3]-bradykinin (CHEBI:133051) is conjugate base of [Hyp3]-bradykinin(2+) (CHEBI:133054) |
| IUPAC Name |
|---|
| 1-[(2S)-2-azaniumyl-5-{[azaniumyl(imino)methyl]amino}pentanoyl]-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-L-phenylalanyl-L-seryl-L-prolyl-N-[(1S)-4-{[azaniumyl(imino)methyl]amino}-1-carboxylatobutyl]-L-phenylalaninamide |
| Synonyms | Source |
|---|---|
| bradykinin, hydroxy-pro(3) | ChEBI |
| Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg(2+) | ChEBI |
| L-Arg-L-Pro-L-Hyp-Gly-L-Phe-L-Ser-L-Pro-L-Phe-L-Arg(2+) | ChEBI |